Animal Blood & Blood Components - Global Strategic Business Report 2026

The global market for Animal Blood & Blood Components was valued at US$142.1 Million in 2025 and is projected to reach US$267.5 Million by 2032, growing at a CAGR of 9.5% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Animal Blood & Blood Components Market - Key Trends & Drivers Summarized

Why Is Demand for Animal Blood & Blood Components Increasing Across Various Industries?

The demand for animal blood and its components is rising across multiple industries due to its wide-ranging applications in pharmaceuticals, animal feed, food processing, and diagnostics. The increasing use of animal blood derivatives such as plasma, hemoglobin, and serum proteins in the production of vaccines, therapeutic products, and biopharmaceuticals is a key factor driving market growth. The animal feed industry has also emerged as a significant consumer, with blood meal and plasma proteins being used as high-protein dietary supplements to enhance livestock nutrition and growth. In addition, the food processing industry is incorporating animal blood components in the production of functional foods and nutritional supplements, leveraging their rich amino acid and protein content. The growing awareness of sustainable resource utilization is further encouraging industries to explore innovative applications of animal blood by-products, reducing waste and maximizing value from animal processing.

How Are Technological Advancements Driving Innovation in the Market?

Technological advancements in processing and separation techniques are revolutionizing the production and application of animal blood components. Innovations in fractionation and purification processes are enabling the extraction of high-value proteins and bioactive compounds with enhanced functional properties, making them suitable for specialized applications in biotechnology and pharmaceuticals. The adoption of advanced sterilization and preservation technologies is also improving the shelf life and stability of blood-derived products, ensuring their quality and efficacy for end-users. Additionally, research in biotechnology and molecular biology is facilitating the development of novel products such as immunoglobulin-rich plasma and bioactive peptides derived from animal blood, offering potential benefits for immune health, wound healing, and nutraceutical applications. As these technological advancements continue to evolve, manufacturers are focusing on improving product consistency, reducing processing costs, and enhancing safety standards to meet regulatory requirements across different regions.

What Challenges and Opportunities Exist in the Animal Blood & Blood Components Market?

The animal blood and blood components market faces several challenges, including regulatory hurdles, ethical concerns, and variability in raw material supply. Stringent regulatory frameworks governing the collection, processing, and use of animal-derived materials, particularly in the food and pharmaceutical industries, present compliance challenges for market players. Ethical concerns related to animal welfare and the sourcing of blood products have also prompted industry stakeholders to adopt more transparent and sustainable sourcing practices. Additionally, the potential risks of contamination and disease transmission require rigorous quality control measures, further adding to operational complexities. However, these challenges present opportunities for innovation and market differentiation. The increasing focus on alternative protein sources, growing demand for clean-label and sustainable ingredients, and the expansion of research in biomaterials and regenerative medicine offer promising growth avenues for animal blood-derived products. Companies investing in eco-friendly processing technologies and robust traceability systems are well-positioned to capitalize on emerging opportunities in this evolving market.

What Are the Key Factors Driving Growth in the Animal Blood & Blood Components Market?

The growth in the Animal Blood & Blood Components market is driven by several factors, including the rising demand for high-protein animal feed, expanding applications in pharmaceuticals, and increasing utilization in food processing. The growing global population and the rising need for efficient livestock production are fueling the demand for blood-based feed additives that enhance animal health and productivity. The pharmaceutical industry's increasing reliance on blood-derived proteins for vaccine production, cell culture media, and biopharmaceutical development is another major growth driver. Additionally, the growing trend of functional foods and dietary supplements incorporating animal blood components is contributing to market expansion. Government initiatives promoting sustainable resource utilization and advancements in processing technologies are expected to further accelerate market growth in the coming years.

Report Scope

The report analyzes the Animal Blood & Blood Components market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Type (Animal Blood Components, Animal Whole Blood); Animal Size (Large Animals, Small Animals); Application (Anemia Application, Surgery Application, Bleeding Disorders Application, Other Applications).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Animal Blood Components segment, which is expected to reach US$161.3 Million by 2032 with a CAGR of a 11.1%. The Animal Whole Blood segment is also set to grow at 7.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $41.6 Million in 2025, and China, forecasted to grow at an impressive 8.9% CAGR to reach $46.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Animal Blood & Blood Components Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Animal Blood & Blood Components Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Animal Blood & Blood Components Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Animal Technologies, Inc., Biowest SAS, Bovogen Biologicals Pty Ltd., Kraeber & Co GmbH, Lake Immunogenics, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Animal Blood & Blood Components market report include:

• Animal Technologies, Inc.
• Biowest SAS
• Bovogen Biologicals Pty Ltd.
• Kraeber & Co GmbH
• Lake Immunogenics, Inc.
• LAMPIRE Biological Laboratories, Inc.
• PAN-Biotech GmbH
• Pel-Freez, LLC
• Rocky Mountain Biologicals, LLC
• Serana Europe GmbH
• TCS Biosciences Ltd.
• Thermo Fisher Scientific, Inc.

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.